Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Sonoma Pharmaceuticals, Inc.

NASDAQ: SNOAHealthcare / Drug Manufacturers - Other / USA
0.8200+0.0600+7.89%Vol 174 9411Y Perf -80.89%
Feb 21st, 2019 15:57
BID0.8000 ASK0.8200
Open0.8000 Previous Close0.7600
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.00 
Analyst Rating
Moderate Buy 1.67
Potencial %
509.76 
Finscreener Ranking
★★★+     52.96
Insiders Trans % 3/6/12M
-/-/100 
Value Ranking
★★★     52.77
Insiders Value % 3/6/12M
-/-/100 
Growth Ranking
★★     44.49
Insiders Shares Cnt. % 3/6/12M
-/-/100 
Income Ranking
 —    -
Market Cap (mil)5 
Earnings Rating
Neutral
Price Range Ratio 52wk %
4.33 
Earnings Date
20th Feb 2019

Today's Price Range

0.80000.8200

 

52wk Range

0.64004.80

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
7.89%
3 Months
-7.87%
6 Months
-58.38%
1 Year
-80.89%
3 Years
-83.43%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
SNOA0.82000.06007.89
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
2.30
Current Ratio
3.80
Long Term Debt to Total Capital
0.01
Total Debt to Equity
0.03
Interest Coverage
-363.80
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
44.10
EBIT Margin
-79.70
EBITDA Margin
-77.00
Pre-tax Profit Margin
-75.20
Profit Margin
-84.72
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.77
PS Ratios
0.62
Price to Cash Flow
10.50
Price to Free Cash Flow
-0.80
Cash Flow Per Share
-2.13
Price to Tangible Book
0.77
Book Value per Share
0.97
Enterprise Value (in ths.)
4 526
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-29.52
ROE last 12 Months
-106.26
Return on Assets (5Y Avg)
-22.74
ROA last 12 Months
-82.97
Return on Capital (5Y Avg)
-24.99
ROC last 12 Months
-104.50
Return on invested Capital Q
-23.63
Return on invested Capital Y
-77.13
Assets Turnover
0.60
Receivables Turnover
4.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
12 963
Revenue per Share
1.16
Revenue Growth 3 Years
-1.35
Revenue Growth 5 Years
1.97
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2019-0.21-0.26-23.81
Q02 2019--0.44-
Q01 2019--0.55-
Q04 2018-0.65-0.93-43.08
Q03 2018-0.63-0.73-15.87
Q02 2018-0.75-0.6710.67
Q01 2017--0.61-
Q04 2016--0.16-
Earnings Per EndEstimateRevision %Trend
3/2019 QR-0.2090.00Positive
3/2019 QR-0.20--
3/2019 FY-1.21--
3/2019 FY-2.200.00-
Next Report Date-
Estimated EPS Next Report-0.21
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume174 941
Shares Outstanding (in ths.)6 593
Trades Count219
Dollar Volume140 177
Avg. Volume90 551
Avg. Weekly Volume209 655
Avg. Monthly Volume84 339
Avg. Quarterly Volume106 715

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

58%42%

Bearish Bullish

65%35%

Bearish Bullish

70%30%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News